Pacific Biosciences of California Inc (NASDAQ:PACB) currently has a daily average trading volume of 9.76M but it saw 7108562 shares traded in last market. With a market cap of 560.05M USD, the company’s current market price of $2.05 came falling about -9.91 while comparing to the previous closing price of $2.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.65 and as low as $1.16. In the recent trading on the day, stock has struck highest price mark of $2.0301 while lowest mark touched by it was $2.29.
Taking a look at 20-day trading activity of Pacific Biosciences of California Inc (PACB) gives us an average price of $1.90, while its current price level is -80.80% below from 52-week high level whereas it is 76.29% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.97 while that of 200 days or SMA-200 reads an average of $2.10. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.46% during that period while stretching the period over a month that decreases to 11.02%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 51.36 which implies that the stock is in neutral territory.
Over the week, PACB’s stock price is moving 3.28% up while it is -7.26% when we observe its performance for the past one month. Year-to-date it is -79.15% down and over the past year, the stock is showing a downside performance of -75.39%.
The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -0.81. In next quarter, company is expected to be making quarterly sales of $42.67M as analysts are expecting the sales for current fiscal year at $155.49M and seeing the company making $191.51M in sales next year. Moreover, analysts are in estimates of $40.66M for current-quarter revenue.
Currently, Pacific Biosciences of California Inc’s total number of outstanding shares is 273.81M. Company’s return on investment (ROI) stands at -28.92% and return on equity (ROE) at -64.80%. Stock’s beta reads 1.95. Stock has a price to book (P/B) ratio of 1.24 while price to sale or P/S ratio amounts to 3.23. Its return on asset (ROA) is -23.55% on average.
